Although half of patients with Type 2 diabetes (T2D) in France have blood glucose levels that are outside of their target range, an international consensus suggests that
A team of University of British Columbia (UBC) researchers has discovered that insulin from the oral insulin tablets they are developing is absorbed by rats
The US Food and Drug Administration (FDA) has approved Mounjaro (tirzepatide), Eli Lilly and Company’s new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1)
Metformin is the first drug prescribed to most new patients with Type 2 diabetes and is increasingly popular for use with patients with Type 1
While zero-calorie sweeteners bring a little sweetness to our lives without prompting significant or obvious blood sugar spikes and are said to pass through the
The American Diabetes Association(ADA), has applauded U.S. Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME) for recently introducing legislation which aims to make insulin more
Eli Lilly has received FDA approval and expanded labelling for its Lyumjev rapid-acting insulin. Lyumjev is a novel formulation of insulin lispro for speeding up
The FDA has approved an extended-release version of the GLP-1 drug exenatide for older children and teenagers with Type 2 diabetes, Andrew Briskin report for
On 14 July Eli Lilly and Company announced the acquisition of Protomer Technologies (“Protomer”), a private biotech company. Protomer’s proprietary peptide- and protein-engineering platform is
Spirit Pharmacy, the UK’s only home delivery pharmacy offering tailored services for people living with diabetes, has launched its free Live Well With Diabetes package.
